Compound details
Quassimarin
| Compound ID | CDAMM01024 |
|---|---|
| Common name | Quassimarin | IUPAC name | (12,15,16-trihydroxy-9,13,17-trimethyl-4,11-dioxo-5,18-dioxapentacyclo[12.5.0.01,6.02,17.08,13]nonadec-9-en-3-yl) 2-acetyloxy-2-methylbutanoate |
| Molecular formula | C27H36O11 |
| Retention time | 0.41 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 537.234 | Theoretical mz | 537.233 |
| Error | 1.35 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.9444 |
| Inchi key | FXMIXHYJCNZLFE-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C(OC(C(=O)OC1C(=O)OC2CC3C(=CC(=O)C(O)C3(C)C4C(O)C(O)C5(OCC24C15)C)C)(C)CC)C |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P29274 | ADORA2A | Adenosine A2a receptor | T77365 | SwissTargetPrediction |
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| P00734 | F2 | Thrombin | T94033 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| Q8IXJ6 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | T83904 | SwissTargetPrediction |
| P27487 | DPP4 | Dipeptidyl peptidase IV | T31391 | SwissTargetPrediction |
| P13866 | SLC5A1 | Sodium/glucose cotransporter 1 | T54771 | SwissTargetPrediction |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| P35354 | PTGS2 | Cyclooxygenase-2 | T66665 | SwissTargetPrediction |
| P10275 | AR | Androgen Receptor | T11211 | SwissTargetPrediction |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| P08235 | NR3C2 | Mineralocorticoid receptor | T72168 | SwissTargetPrediction |
| P04150 | NR3C1 | Glucocorticoid receptor | T40016 | SwissTargetPrediction |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SwissTargetPrediction |
| P28845 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | T65200 | SwissTargetPrediction |
| Q9UM73 | ALK | ALK tyrosine kinase receptor | T56418 | SwissTargetPrediction |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SwissTargetPrediction |
| P14061 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | T44011 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | T08391 | SwissTargetPrediction |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SwissTargetPrediction |
| P11802 | CDK4 | Cyclin-dependent kinase 4 | T85799 | SwissTargetPrediction |
| P56817 | BACE1 | Beta-secretase 1 | T79031 | SwissTargetPrediction |
| P78536 | ADAM17 | ADAM17 | T82393 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P00742 | F10 | Thrombin and coagulation factor X | T84631 | SwissTargetPrediction |
| P62942 | FKBP1A | FK506-binding protein 1A | T76059 | SwissTargetPrediction |
| O14746 | TERT | Telomerase reverse transcriptase | T86052 | SwissTargetPrediction |
| O00767 | SCD | Acyl-CoA desaturase | T10897 | SwissTargetPrediction |
| Q08499 | PDE4D | Phosphodiesterase 4D | T02001 | SwissTargetPrediction |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SwissTargetPrediction |
| P24723 | PRKCH | Protein kinase C eta | T40149 | SwissTargetPrediction |
| P80365 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | T43721 | SwissTargetPrediction |
| P11387 | TOP1 | DNA topoisomerase I | T09826 | SwissTargetPrediction |
| P23458 | JAK1 | Tyrosine-protein kinase JAK1 | T62460 | SwissTargetPrediction |
| P05771 | PRKCB | Protein kinase C beta | T40276 | SwissTargetPrediction |
| Q02156 | PRKCE | Protein kinase C epsilon | T00895 | SwissTargetPrediction |
| Q5S007 | LRRK2 | Leucine-rich repeat serine/threonine-protein kinase 2 | T08123 | SwissTargetPrediction |
| Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | T99057 | SwissTargetPrediction |
| P08581 | MET | Hepatocyte growth factor receptor | T40474 | SwissTargetPrediction |
| O00329 | PIK3CD | PI3-kinase p110-delta subunit | T67849 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| Q99572 | P2RX7 | P2X purinoceptor 7 | T63414 | SwissTargetPrediction |
| P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | T09538 | SwissTargetPrediction |
| P35916 | FLT4 | Vascular endothelial growth factor receptor 3 | T07303 | SwissTargetPrediction |
| P29466 | CASP1 | Caspase-1 | T98269 | SwissTargetPrediction |
| Q05655 | PRKCD | Protein kinase C delta | T44861 | SwissTargetPrediction |
| Q9NWZ3 | IRAK4 | Interleukin-1 receptor-associated kinase 4 | T55398 | SwissTargetPrediction |
| P28482 | MAPK1 | MAP kinase ERK2 | T58970 | SwissTargetPrediction |
| P41279 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | T00852 | SwissTargetPrediction |
| P11362 | FGFR1 | Fibroblast growth factor receptor 1 | T47101 | SwissTargetPrediction |
| P55263 | ADK | Adenosine kinase | T91661 | SwissTargetPrediction |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SwissTargetPrediction |
| Q99808 | SLC29A1 | Equilibrative nucleoside transporter 1 | T13491 | SwissTargetPrediction |
| O43868 | SLC28A2 | Sodium/nucleoside cotransporter 2 | T94627 | SwissTargetPrediction |
| P48167 | GLRB | Glycine receptor | T55285 | SwissTargetPrediction |
| P31644 | GABRA5 | GABA receptor alpha-5 subunit | T26368 | SwissTargetPrediction |
| P04629 | NTRK1 | Nerve growth factor receptor Trk-A | T07173 | SwissTargetPrediction |
| P31639 | SLC5A2 | Sodium/glucose cotransporter 2 | T30085 | SwissTargetPrediction |
| P06737 | PYGL | Liver glycogen phosphorylase | T19184 | SwissTargetPrediction |
| Q99558 | MAP3K14 | Mitogen-activated protein kinase kinase kinase 14 | T95736 | SwissTargetPrediction |
| P55085 | F2RL1 | Proteinase-activated receptor 2 | T62841 | SwissTargetPrediction |
| P25025 | CXCR2 | Interleukin-8 receptor B | T56923 | SwissTargetPrediction |
| P50281 | MMP14 | Matrix metalloproteinase 14 | T65019 | SwissTargetPrediction |
| Q9UQ81 | MCH5 | Caspase-8 | T15700 | SwissTargetPrediction |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SwissTargetPrediction |
| Q04759 | PRKCQ | Protein kinase C theta | T23995 | SwissTargetPrediction |
| P12268 | IMPDH2 | Inosine-5'-monophosphate dehydrogenase 2 | T89360 | SwissTargetPrediction |
| P08151 | GLI1 | Zinc finger protein GLI1 | T40890 | SwissTargetPrediction |
| P56373 | P2RX3 | P2X purinoceptor 3 | T17140 | SwissTargetPrediction |
| P08709 | F7 | Coagulation factor VII | T43332 | SwissTargetPrediction |
| P37023 | ACVRL1 | Serine/threonine-protein kinase receptor R3 | T36959 | SwissTargetPrediction |
| P17931 | LGALS3 | Galectin-3 | T72038 | SwissTargetPrediction |
| P53609 | PGGT1B | Geranylgeranyl transferase type I | T76396 | SwissTargetPrediction |
| P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha 3 | T03279 | SwissTargetPrediction |
| P22001 | KCNA3 | Voltage-gated potassium channel subunit Kv1.3 | T76914 | SwissTargetPrediction |
| Q9UK32 | RPS6KA6 | Ribosomal protein S6 kinase alpha 6 | T95878 | SwissTargetPrediction |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| Q8WTV0 | SCARB1 | Scavenger receptor class B member 1 (by homology) | T62998 | SwissTargetPrediction |
| P49674 | CSNK1E | Casein kinase I epsilon | T99989 | SwissTargetPrediction |
| Q00796 | SORD | Sorbitol dehydrogenase | T59445 | SwissTargetPrediction |
| P20248 | CCNA2 | CDK2/Cyclin A | T58470 | SwissTargetPrediction |
| P40337 | VHL | Von Hippel-Lindau disease tumor suppressor/Elongin B/Elongin C | T80423 | SwissTargetPrediction |
| Q15759 | MAPK11 | MAP kinase p38 beta | T55729 | SwissTargetPrediction |
| P05129 | PRKCG | Protein kinase C gamma | T47107 | SwissTargetPrediction |
| Q08828 | ADCY1 | Brain adenylate cyclase 1 | T63609 | SwissTargetPrediction |
| Q9HBA0 | TRPV4 | Transient receptor potential cation channel subfamily V member 4 | T64213 | SwissTargetPrediction |
| P09382 | LGALS1 | Galectin-1 | T09544 | SwissTargetPrediction |
| O00142 | TK2 | Thymidine kinase, mitochondrial | T22976 | SwissTargetPrediction |
| P00740 | F9 | Coagulation factor IX | T83369 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T77365 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P29274 | ADORA2A |
| T77365 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P29274 | ADORA2A |
| T77365 | DI0359 | Radionuclide imaging | [ICD-11: N.A.] | P29274 | ADORA2A |
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T94033 | DI0052 | Bleeding disorder | [ICD-11: GA20-GA21] | P00734 | F2 |
| T94033 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00734 | F2 |
| T94033 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P00734 | F2 |
| T94033 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P00734 | F2 |
| T94033 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P00734 | F2 |
| T94033 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P00734 | F2 |
| T94033 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P00734 | F2 |
| T94033 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P00734 | F2 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T83904 | DI0365 | Retinopathy | [ICD-11: 9B71] | Q8IXJ6 | SIRT2 |
| T31391 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P27487 | DPP4 |
| T31391 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P27487 | DPP4 |
| T54771 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P13866 | SLC5A1 |
| T54771 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P13866 | SLC5A1 |
| T54771 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P13866 | SLC5A1 |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T66665 | DI0087 | Chronic pain | [ICD-11: MG30] | P35354 | PTGS2 |
| T66665 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P35354 | PTGS2 |
| T66665 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P35354 | PTGS2 |
| T66665 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P35354 | PTGS2 |
| T66665 | DI0227 | Knee osteoarthritis | [ICD-11: FA01] | P35354 | PTGS2 |
| T66665 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35354 | PTGS2 |
| T66665 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35354 | PTGS2 |
| T66665 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P35354 | PTGS2 |
| T66665 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | P35354 | PTGS2 |
| T11211 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P10275 | AR |
| T11211 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10275 | AR |
| T11211 | DI0021 | Alcoholic liver disease | [ICD-11: DB94] | P10275 | AR |
| T11211 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10275 | AR |
| T11211 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P10275 | AR |
| T11211 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P10275 | AR |
| T11211 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P10275 | AR |
| T11211 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P10275 | AR |
| T11211 | DI0247 | Mammary tumour | [ICD-11: 2C60-2C6Z] | P10275 | AR |
| T11211 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P10275 | AR |
| T11211 | DI0401 | Testicular dysfunction | [ICD-11: 5A81] | P10275 | AR |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T72168 | DI0018 | Adrenocortical insufficiency | [ICD-11: 5A74] | P08235 | NR3C2 |
| T72168 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P08235 | NR3C2 |
| T72168 | DI0100 | Contraceptive management | [ICD-11: QA21] | P08235 | NR3C2 |
| T72168 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08235 | NR3C2 |
| T72168 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08235 | NR3C2 |
| T72168 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P08235 | NR3C2 |
| T40016 | DI0016 | Adaptive immunity immunodeficiency | [ICD-11: 4A01] | P04150 | NR3C1 |
| T40016 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P04150 | NR3C1 |
| T40016 | DI0037 | Asthma | [ICD-11: CA23] | P04150 | NR3C1 |
| T40016 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P04150 | NR3C1 |
| T40016 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P04150 | NR3C1 |
| T40016 | DI0280 | Muscular dystrophy | [ICD-11: 8C70] | P04150 | NR3C1 |
| T40016 | DI0314 | Oesophagitis | [ICD-11: DA24] | P04150 | NR3C1 |
| T40016 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P04150 | NR3C1 |
| T40016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P04150 | NR3C1 |
| T40016 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04150 | NR3C1 |
| T40016 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | P04150 | NR3C1 |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T65200 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P28845 | HSD11B1 |
| T65200 | DI0239 | Lupus erythematosus | [ICD-11: 4A40] | P28845 | HSD11B1 |
| T65200 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P28845 | HSD11B1 |
| T56418 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q9UM73 | ALK |
| T56418 | DI0251 | Mature T-cell lymphoma | [ICD-11: 2A90] | Q9UM73 | ALK |
| T56418 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | Q9UM73 | ALK |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T08391 | DI0039 | Atopic eczema | [ICD-11: EA80] | O60674 | JAK2 |
| T08391 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60674 | JAK2 |
| T08391 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O60674 | JAK2 |
| T08391 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | O60674 | JAK2 |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T85799 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11802 | CDK4 |
| T85799 | DI0238 | Lung cancer | [ICD-11: 2C25] | P11802 | CDK4 |
| T85799 | DI0351 | Psoriasis | [ICD-11: EA90] | P11802 | CDK4 |
| T79031 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P56817 | BACE1 |
| T82393 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P78536 | ADAM17 |
| T82393 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P78536 | ADAM17 |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T84631 | DI0053 | Blood-forming organ disease | [ICD-11: 3C0Z] | P00742 | F10 |
| T84631 | DI0080 | Christmas disease | [ICD-11: 3B11] | P00742 | F10 |
| T84631 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00742 | F10 |
| T84631 | DI0103 | Coronary thrombosis | [ICD-11: BA43] | P00742 | F10 |
| T84631 | DI0114 | Deep vein thrombosis | [ICD-11: BD71] | P00742 | F10 |
| T84631 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P00742 | F10 |
| T84631 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P00742 | F10 |
| T84631 | DI0433 | Venous thromboembolism | [ICD-11: BD72] | P00742 | F10 |
| T76059 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P62942 | FKBP1A |
| T76059 | DI0349 | Pruritus | [ICD-11: EC90] | P62942 | FKBP1A |
| T76059 | DI0413 | Transplant rejection | [ICD-11: NE84] | P62942 | FKBP1A |
| T86052 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | O14746 | TERT |
| T86052 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O14746 | TERT |
| T86052 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14746 | TERT |
| T10897 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O00767 | SCD |
| T02001 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | Q08499 | PDE4D |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T40149 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P24723 | PRKCH |
| T43721 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P80365 | HSD11B2 |
| T09826 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P11387 | TOP1 |
| T09826 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P11387 | TOP1 |
| T09826 | DI0238 | Lung cancer | [ICD-11: 2C25] | P11387 | TOP1 |
| T09826 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P11387 | TOP1 |
| T09826 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11387 | TOP1 |
| T62460 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23458 | JAK1 |
| T62460 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P23458 | JAK1 |
| T62460 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P23458 | JAK1 |
| T62460 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | P23458 | JAK1 |
| T40276 | DI0123 | Diffuse large B-cell lymphoma | [ICD-11: 2A81] | P05771 | PRKCB |
| T40276 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P05771 | PRKCB |
| T40276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P05771 | PRKCB |
| T00895 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | Q02156 | PRKCE |
| T00895 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q02156 | PRKCE |
| T08123 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q5S007 | LRRK2 |
| T99057 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | Q02750 | MAP2K1 |
| T99057 | DI0336 | Phakomatoses/hamartoneoplastic syndrome | [ICD-11: LD2D] | Q02750 | MAP2K1 |
| T40474 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P08581 | MET |
| T67849 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | O00329 | PIK3CD |
| T67849 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00329 | PIK3CD |
| T67849 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | O00329 | PIK3CD |
| T67849 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | O00329 | PIK3CD |
| T67849 | DI0395 | Stomach cancer | [ICD-11: 2B72] | O00329 | PIK3CD |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T63414 | DI0224 | Joint pain | [ICD-11: ME82] | Q99572 | P2RX7 |
| T09538 | DI0164 | Genetic prion disease | [ICD-11: 8E02] | P05186 | ALPL |
| T09538 | DI0330 | Parasitic infection | [ICD-11: 1D0Y-1G2Z] | P05186 | ALPL |
| T07303 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P35916 | FLT4 |
| T98269 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P29466 | CASP1 |
| T98269 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | P29466 | CASP1 |
| T98269 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P29466 | CASP1 |
| T98269 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P29466 | CASP1 |
| T44861 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q05655 | PRKCD |
| T55398 | DI0039 | Atopic eczema | [ICD-11: EA80] | Q9NWZ3 | IRAK4 |
| T55398 | DI0109 | Cutaneous lupus erythematosus | [ICD-11: EB50-EB5Z] | Q9NWZ3 | IRAK4 |
| T55398 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9NWZ3 | IRAK4 |
| T55398 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q9NWZ3 | IRAK4 |
| T55398 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9NWZ3 | IRAK4 |
| T55398 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9NWZ3 | IRAK4 |
| T58970 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P28482 | MAPK1 |
| T58970 | DI0252 | Melanoma | [ICD-11: 2C30] | P28482 | MAPK1 |
| T58970 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P28482 | MAPK1 |
| T58970 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28482 | MAPK1 |
| T00852 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P41279 | MAP3K8 |
| T47101 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P11362 | FGFR1 |
| T47101 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P11362 | FGFR1 |
| T47101 | DI0235 | Liver cancer | [ICD-11: 2C12] | P11362 | FGFR1 |
| T47101 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P11362 | FGFR1 |
| T91661 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P55263 | ADK |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T13491 | DI0030 | Angina pectoris | [ICD-11: BA40] | Q99808 | SLC29A1 |
| T55285 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P48167 | GLRB |
| T26368 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P31644 | GABRA5 |
| T07173 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04629 | NTRK1 |
| T07173 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04629 | NTRK1 |
| T30085 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P31639 | SLC5A2 |
| T30085 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P31639 | SLC5A2 |
| T30085 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P31639 | SLC5A2 |
| T62841 | DI0087 | Chronic pain | [ICD-11: MG30] | P55085 | F2RL1 |
| T56923 | DI0155 | Fungal infection | [ICD-11: 1F29-1F2F] | P25025 | CXCR2 |
| T56923 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P25025 | CXCR2 |
| T65019 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P50281 | MMP14 |
| T15700 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | Q9UQ81 | MCH5 |
| T15700 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UQ81 | MCH5 |
| T23995 | DI0413 | Transplant rejection | [ICD-11: NE84] | Q04759 | PRKCQ |
| T89360 | DI0413 | Transplant rejection | [ICD-11: NE84] | P12268 | IMPDH2 |
| T17140 | DI0105 | Cough | [ICD-11: MD12] | P56373 | P2RX3 |
| T43332 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P08709 | F7 |
| T36959 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P37023 | ACVRL1 |
| T72038 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P17931 | LGALS3 |
| T72038 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P17931 | LGALS3 |
| T72038 | DI0252 | Melanoma | [ICD-11: 2C30] | P17931 | LGALS3 |
| T72038 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | P17931 | LGALS3 |
| T72038 | DI0351 | Psoriasis | [ICD-11: EA90] | P17931 | LGALS3 |
| T76396 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P53609 | PGGT1B |
| T03279 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P51812 | RPS6KA3 |
| T76914 | DI0198 | Idiopathic inflammatory myopathy | [ICD-11: 4A41] | P22001 | KCNA3 |
| T76914 | DI0351 | Psoriasis | [ICD-11: EA90] | P22001 | KCNA3 |
| T76914 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P22001 | KCNA3 |
| T95878 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q9UK32 | RPS6KA6 |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T99989 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P49674 | CSNK1E |
| T99989 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P49674 | CSNK1E |
| T58470 | DI0363 | Retina cancer | [ICD-11: 2D02] | P20248 | CCNA2 |
| T55729 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q15759 | MAPK11 |
| T55729 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q15759 | MAPK11 |
| T47107 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P05129 | PRKCG |
| T47107 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P05129 | PRKCG |
| T63609 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q08828 | ADCY1 |
| T64213 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q9HBA0 | TRPV4 |
| T64213 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q9HBA0 | TRPV4 |
| T64213 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | Q9HBA0 | TRPV4 |
| T22976 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | O00142 | TK2 |
| T83369 | DI0052 | Bleeding disorder | [ICD-11: GA20-GA21] | P00740 | F9 |
| T83369 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00740 | F9 |